MEYER ANDREW HOLLMAN (Chief Business Officer) sold 3.9% of their position (3.33K shares) of JANUX THERAPEUTICS, INC. on the open market
Open‑market sale worth $106.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/2/2025ACC: 0001415889-25-011874
Officer· Chief Business Officer
Since Jun 2021
-3.33K
Net shares
Net seller
$106.7K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
3.33K acquired · 6.67K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3.33K
Price / share
$4.21
Trade value
$14.03K
% of position
4.1%
5/1/2025
82.14K→85.47K
Common Stock
Direct
Shares
−2.93K
Price / share
$31.95
Trade value
$93.70K
% of position
3.4%
5/1/2025
85.47K→82.54K
Common Stock
Direct
Shares
−400.00
Price / share
$32.60
Trade value
$13.04K
% of position
0.5%
5/1/2025
82.54K→82.14K
Total
Net shares
+0.00
Net value
-$92.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2025 | M · Option Exercise | +3.33K | $4.21 | $14.03K | 4.1% | 82.14K | 85.47K |
| Common Stock Direct | 5/1/2025 | S · Sale | −2.93K | $31.95 | $93.70K | 3.4% | 85.47K | 82.54K |
| Common Stock Direct | 5/1/2025 | S · Sale | −400.00 | $32.60 | $13.04K | 0.5% | 82.54K | 82.14K |
| Total | +0.00 | -$92.71K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
3.33K shares
Shares
−3.33K
Strike price
4.21
Held after
87.33K
Exercisable
—
5/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3.33K shares | 5/1/2025 | M · Option Exercise | −3.33K | 4.21 | — | 87.33K |